Of Interest

A new trial program in regional Victoria is working with artificial technology to fast-track skin cancer diagnosis.

Single-dose neoadjuvant pembrolizumab was safe with no surgical delays and boosted MPR rates in resectable melanoma.

Back in 2014, a woman with advanced cancer pushed Adrienne Boire’s scientific life in a whole new direction. The cancer, which had begun in the breast, had found its way into the patient’s spinal fluid, rendering the middle-aged mother of two unable to walk. “When did this happen?” she asked from her hospital bed. “Why are the cells growing there?”

The following provides a brief summary of some notable trends in the latest cancer data. More comprehensive data is available throughout the Cancer data in Australia report for the cancers summarised as well as many other cancers.